SCHEMBL13462039

SCHEMBL13462039

CC(=O)OCC1OC(n2cnc3c(=O)[nH]c(N)nc32)C(OC(C)=O)[C@@H]1OC(C)=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.68
▸ LMNA P02545 2/20 0.66
▸ TP53 P04637 1/20 0.66
▸ MAPT P10636 1/20 0.66
▸ TDP1 Q9NUW8 1/20 0.66
▸ HINT1 P49773 6/20 0.61
▸ GSK3A P49840 2/20 0.56
▸ RPS6KA3 P51812 2/20 0.56
▸ MAPK14 Q16539 2/20 0.56
▸ TAS1R3 Q7RTX0 1/20 0.54
▸ TAS1R1 Q7RTX1 1/20 0.54
▸ PNP P00491 1/20 0.53
▸ NT5E P21589 1/20 0.52
▸ THRB P10828 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ HIF1A Q16665 1/20 0.52
▸ PRKAB2 O43741 1/20 0.51
▸ PRKAG1 P54619 1/20 0.51
▸ PRKAA2 P54646 1/20 0.51
▸ PRKAA1 Q13131 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1061031 1.00 ALDH1A1 (0.68) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL314536 1.00 ALDH1A1 (0.68) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL14144174 1.00 ALDH1A1 (0.68) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL278167 1.00 ALDH1A1 (0.68) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL1120690 1.00 ALDH1A1 (0.68) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL4386265 1.00 ALDH1A1 (0.68) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL25407962 1.00 ALDH1A1 (0.68) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL3422978 1.00 ALDH1A1 (0.68) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL13296251 1.00 ALDH1A1 (0.68) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL18852518 0.95 ALDH1A1 (0.63) ALDH1A1LMNATP53MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7683037-B2 A2A receptor agonist; regadenoson (CVT-3146); produces coronary vasodilation without significant peripheral vasodilation; GILEAD PALO ALTO, INC. (US) 2010-03-23 — — US disclosed
Send feedback